Literature DB >> 27631338

Morphological, immunohistochemical, and chromosomal analysis of multicystic chromophobe renal cell carcinoma, an architecturally unusual challenging variant.

Maria Pané Foix1,2, Ana Dunatov3, Petr Martinek4, Enric Condom Mundó1,2, Saul Suster5, Maris Sperga6, Jose I Lopez7, Monika Ulamec8, Stela Bulimbasic9, Delia Perez Montiel10, Reza Alaghehbandan11, Kvetoslava Peckova4, Krystina Pivovarcikova4, Daum Ondrej4, Pavla Rotterova4, Faruk Skenderi12, Kristyna Prochazkova13, Martin Dusek4, Milan Hora13, Michal Michal4, Ondrej Hes14,15.   

Abstract

Chromophobe renal cell carcinoma (ChRCC) is typically composed of large leaf-like cells and smaller eosinophilic cells arranged in a solid-alveolar pattern. Eosinophilic, adenomatoid/pigmented, or neuroendocrine variants have also been described. We collected 10 cases of ChRCC with a distinct multicystic pattern out of 733 ChRCCs from our registry, and subsequently analyzed these by morphology, immunohistochemistry, and array comparative genomic hybridization. Of the 10 patients, 6 were males with an age range of 50-89 years (mean 68, median 69). Tumor size ranged between 1.2 and 20 cm (mean 5.32, median 3). Clinical follow-up was available for seven patients, ranging 1-19 years (mean 7.2, median 2.5). No aggressive behavior was documented. We observed two growth patterns, which were similar in all tumors: (1) variable-sized cysts, resembling multilocular cystic neoplasm of low malignant potential and (2) compressed cystic and tubular pattern with slit-like spaces. Raisinoid nuclei were consistently present while necrosis was absent in all cases. Half of the cases showed eosinophilic/oncocytic cytology, deposits of pigment (lipochrome) and microcalcifications. The other half was composed of pale or mixed cell populations. Immunostains for epithelial membrane antigen (EMA), CK7, OSCAR, CD117, parvalbumin, MIA, and Pax 8 were positive in all tumors while negative for vimentin, TFE3, CANH 9, HMB45, cathepsin K, and AMACR. Ki67 immunostain was positive in up to 1 % of neoplastic cells. Molecular genetic examination revealed multiple chromosomal losses in two fifths analyzable tumors, while three cases showed no chromosomal numerical aberrations. ChRCC are rarely arranged in a prominent multicystic pattern, which is probably an extreme form of the microcystic adenomatoid pigmented variant of ChRCC. The spectrum of tumors entering the differential diagnosis of ChRCC is quite different from that of conventional ChRCC. The immunophenotype of ChRCC is identical with that of conventional ChRCC. Chromosomal numerical aberration pattern was variable; no chromosomal numerical aberrations were found in three cases. All the cases in this series have shown an indolent and non-aggressive behavior.

Entities:  

Keywords:  ArrayCGH; Chromophobe renal cell carcinoma; Immunohistochemistry; Kidney; Multicystic

Mesh:

Substances:

Year:  2016        PMID: 27631338     DOI: 10.1007/s00428-016-2022-x

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  47 in total

1.  Tubulocystic renal cell carcinoma is an entity that is immunohistochemically and genetically distinct from papillary renal cell carcinoma.

Authors:  Thu Tran; Carol L Jones; Sean R Williamson; John N Eble; David J Grignon; Shaobo Zhang; Mingsheng Wang; Lee Ann Baldridge; Lisha Wang; Rodolfo Montironi; Marina Scarpelli; Puay-Hoon Tan; Novae B Simper; Eva Comperat; Liang Cheng
Journal:  Histopathology       Date:  2015-10-21       Impact factor: 5.087

2.  Renal chromophobe cell carcinoma and oncocytoma. A comparative morphologic, histochemical, and immunohistochemical study of 124 cases.

Authors:  B Cochand-Priollet; V Molinié; J Bougaran; R Bouvier; M C Dauge-Geffroy; S Deslignières; J C Fournet; P Gros; A Lesourd; J P Saint-André; M Toublanc; A Vieillefond; M Wassef; A Fontaine; L Groleau
Journal:  Arch Pathol Lab Med       Date:  1997-10       Impact factor: 5.534

Review 3.  Tubulocystic carcinoma, mucinous tubular and spindle cell carcinoma, and other recently described rare renal tumors.

Authors:  Gregory T MacLennan; David G Bostwick
Journal:  Clin Lab Med       Date:  2005-06       Impact factor: 1.935

4.  Chromophobe renal cell carcinoma: an immunohistochemical study of 21 Japanese cases.

Authors:  A Taki; Y Nakatani; K Misugi; M Yao; Y Nagashima
Journal:  Mod Pathol       Date:  1999-03       Impact factor: 7.842

Review 5.  Extensively cystic renal neoplasms: cystic nephroma, cystic partially differentiated nephroblastoma, multilocular cystic renal cell carcinoma, and cystic hamartoma of renal pelvis.

Authors:  J N Eble; S M Bonsib
Journal:  Semin Diagn Pathol       Date:  1998-02       Impact factor: 3.464

6.  Genomic expression and single-nucleotide polymorphism profiling discriminates chromophobe renal cell carcinoma and oncocytoma.

Authors:  Min-Han Tan; Chin Fong Wong; Hwei Ling Tan; Ximing J Yang; Jonathon Ditlev; Daisuke Matsuda; Sok Kean Khoo; Jun Sugimura; Tomoaki Fujioka; Kyle A Furge; Eric Kort; Sophie Giraud; Sophie Ferlicot; Philippe Vielh; Delphine Amsellem-Ouazana; Bernard Debré; Thierry Flam; Nicolas Thiounn; Marc Zerbib; Gérard Benoît; Stéphane Droupy; Vincent Molinié; Annick Vieillefond; Puay Hoon Tan; Stéphane Richard; Bin Tean Teh
Journal:  BMC Cancer       Date:  2010-05-12       Impact factor: 4.430

7.  Chromophobe renal cell carcinoma, oncocytic variant: a proposal of a new variant giving a critical diagnostic pitfall in diagnosing renal oncocytic tumors.

Authors:  Naoto Kuroda; Azusa Tanaka; Tadanori Yamaguchi; Kotaro Kasahara; Keishi Naruse; Yosuke Yamada; Kanako Hatanaka; Nobuo Shinohara; Yoji Nagashima; Shuji Mikami; Mototsugu Oya; Takeru Hamashima; Michal Michal; Ondrej Hes
Journal:  Med Mol Morphol       Date:  2013-01-22       Impact factor: 2.309

8.  Chromophobe renal cell carcinoma--chromosomal aberration variability and its relation to Paner grading system: an array CGH and FISH analysis of 37 cases.

Authors:  Maris Sperga; Petr Martinek; Tomas Vanecek; Petr Grossmann; Kevin Bauleth; Delia Perez-Montiel; Isabel Alvarado-Cabrero; Kristine Nevidovska; Vilnis Lietuvietis; Milan Hora; Michal Michal; Fredrik Petersson; Naoto Kuroda; Saul Suster; Jindrich Branzovsky; Ondrej Hes
Journal:  Virchows Arch       Date:  2013-08-03       Impact factor: 4.064

9.  Pigmented microcystic chromophobe renal cell carcinoma.

Authors:  Pavel Dundr; Michael Pesl; Ctibor Povýsil; Daniel Tvrdík; Ivan Pavlík; Viktor Soukup; Jan Dvorácek
Journal:  Pathol Res Pract       Date:  2007-07-20       Impact factor: 3.250

10.  Immunohistochemical analysis of chromophobe renal cell carcinoma, renal oncocytoma, and clear cell carcinoma: an optimal and practical panel for differential diagnosis.

Authors:  Lina Liu; Junqi Qian; Harpreet Singh; Isabelle Meiers; Xiaoge Zhou; David G Bostwick
Journal:  Arch Pathol Lab Med       Date:  2007-08       Impact factor: 5.534

View more
  8 in total

1.  Renal cell carcinoma: the search for a reliable biomarker.

Authors:  Nicholas J Farber; Christopher J Kim; Parth K Modi; Jane D Hon; Evita T Sadimin; Eric A Singer
Journal:  Transl Cancer Res       Date:  2017-06       Impact factor: 1.241

2.  "High-grade oncocytic renal tumor": morphologic, immunohistochemical, and molecular genetic study of 14 cases.

Authors:  Huiying He; Kiril Trpkov; Petr Martinek; Ozlem Tanas Isikci; Cristina Maggi-Galuzzi; Reza Alaghehbandan; Anthony J Gill; Maria Tretiakova; Jose Ignacio Lopez; Sean R Williamson; Delia Perez Montiel; Maris Sperga; Eva Comperat; Fadi Brimo; Ali Yilmaz; Kristyna Pivovarcikova; Kveta Michalova; David Slouka; Kristyna Prochazkova; Milan Hora; Michael Bonert; Michal Michal; Ondrej Hes
Journal:  Virchows Arch       Date:  2018-09-19       Impact factor: 4.064

Review 3.  Algorithm-Based Approach to the Histological Routine Diagnosis of Renal Oncocytic Tumors in Core Biopsy Specimens.

Authors:  Claudia Manini; Igone Imaz; Aitor Fernández de Larrinoa; José I López
Journal:  Curr Urol Rep       Date:  2022-09-28       Impact factor: 2.862

4.  Cytogenetic and immunohistochemical study of 42 pigmented microcystic chromophobe renal cell carcinoma (PMChRCC).

Authors:  Francisco Javier Queipo Gutiérrez; Ángel Panizo; Antonio Tienza; Irene Rodriguez; Jesús Javier Sola; Jordi Temprana-Salvador; Inés de Torres; Javier Pardo-Mindán
Journal:  Virchows Arch       Date:  2018-06-21       Impact factor: 4.064

5.  Clinicopathological and Molecular Characteristics of Macroscopically Yellowish-Colored Chromophobe Renal Cell Carcinoma Compared to Non-Yellowish-Colored Chromophobe Renal Cell Carcinoma.

Authors:  Fumiyoshi Kojima; Ibu Matsuzaki; Naoto Kuroda; Yurina Mikasa; Fidele Y Musangile; Ryuta Iwamoto; Yuichi Takahashi; Akiko Matsubara; Yasuo Kohjimoto; Isao Hara; Shin-Ichi Murata
Journal:  Clin Pathol       Date:  2021-12-12

Review 6.  Chromophobe renal cell carcinoma: Novel molecular insights and clinicopathologic updates.

Authors:  Reza Alaghehbandan; Christopher G Przybycin; Virginie Verkarre; Rohit Mehra
Journal:  Asian J Urol       Date:  2021-12-01

Review 7.  Molecular Genetics of Renal Cell Tumors: A Practical Diagnostic Approach.

Authors:  Reza Alaghehbandan; Delia Perez Montiel; Ana Silvia Luis; Ondrej Hes
Journal:  Cancers (Basel)       Date:  2019-12-30       Impact factor: 6.639

8.  Small cell variant of chromophobe renal cell carcinoma: Clinicopathologic and molecular-genetic analysis of 10 cases.

Authors:  Joanna Rogala; Fumiyoshi Kojima; Reza Alaghehbandan; Nikola Ptakova; Ana Bravc; Stela Bulimbasic; Delia Perez Montiel; Maryna Slisarenko; Leila Ali; Levente Kuthi; Kristyna Pivovarcikova; Kvetoslava Michalova; Boris Bartovic; Adriena Bartos Vesela; Olga Dolejsova; Michal Michal; Ondrej Hes
Journal:  Bosn J Basic Med Sci       Date:  2022-07-29       Impact factor: 3.759

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.